Reclassifying infusion therapy space at the university of Arizona: A case study

Health Care Manager

Volumn 22, Issue 3, 2003, Pages 203-210

  Baker, Judith J ^a   Bray, Marty ^b   Seashore, Bonnie ^c  

^a Resource Group Ltd   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c Arizona Arthritis Center   (United States)

Author keywords

Decision making; Infusion center; Rheumatology

Indexed keywords

ARTICLE; HEALTH SERVICES RESEARCH; HOSPITAL DEPARTMENT; HOSPITAL DESIGN; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONBIOLOGICAL MODEL; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATIENT TRANSPORT; RHEUMATOLOGY; TASK PERFORMANCE; UNITED STATES; UNIVERSITY HOSPITAL; UTILIZATION REVIEW;

ACADEMIC MEDICAL CENTERS; ARIZONA; DECISION MAKING, ORGANIZATIONAL; HOSPITAL DEPARTMENTS; HOSPITAL DESIGN AND CONSTRUCTION; HUMANS; INFUSIONS, INTRAVENOUS; MODELS, ORGANIZATIONAL; ORGANIZATIONAL CASE STUDIES; PATIENT TRANSFER; RHEUMATOLOGY; TASK PERFORMANCE AND ANALYSIS;

EID: 0141497012     PISSN: 15255794     EISSN: 1550512X     Source Type: Journal    
DOI: 10.1097/00126450-200307000-00003     Document Type: Article

References (2)

1. G.M. Keating and C.M. Perry, “Infliximab: an updated review of its use in Crohn’s disease and rheumatoid arthritis,” BioDrugs 16, no. 2 (2002): 111-148.
2. D. M. Knight et al., “Construction and initial characterization of a mouse-human chimeric anti-TNF antibody,” Molecular Immunology 30, no. 16 (1993).